Cancer cells compensate for the loss of bromodomain transcriptional activity by upregulating BRD4 downstream pathways, such as Wnt/β-catenin, Hedgehog, and RAS-RAF-MAPK (reviewed by [188]), which restore Myc expression. The gene discussed is MYC; the disease is cancer.